Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Health Aff (Millwood) ; 30(9): 1718-27, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21900663

RESUMO

New health care delivery and payment models in the private sector are being shaped by active collaboration between health insurance plans and providers. We examine key characteristics of several of these private accountable care models, including their overall efforts to improve the quality, efficiency, and accountability of care; their criteria for selecting providers; the payment methods and performance measures they are using; and the technical assistance they are supplying to participating providers. Our findings show that not all providers are equally ready to enter into these arrangements with health plans and therefore flexibility in design of these arrangements is critical. These findings also hold lessons for the emerging public accountable care models, such as the Medicare Shared Savings Program-underscoring providers' need for comprehensive and timely data and analytic reports; payment tailored to providers' readiness for these contracts; and measurement of quality across multiple years and care settings.


Assuntos
Organizações de Assistência Responsáveis/economia , Comportamento Cooperativo , Planos de Assistência de Saúde para Empregados , Pessoal de Saúde , Modelos Organizacionais , Setor Privado , Mecanismo de Reembolso/organização & administração , Estados Unidos
2.
Brain Inj ; 22(1): 103-6, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18183514

RESUMO

BACKGROUND: Case reports of the use of zolpidem in Permanent Vegetative States (PVS) have led to interest by the media and court judgements defining treatment with such drugs. It is uncertain whether this paradoxical effect of zolpidem in raising consciousness may be evident in other low awareness states such as Minimally Conscious State (MCS). CASE STUDY: This study treated a 44 year old male with MCS some 4 years after his traumatic brain injury with zolpidem for 1 week on and 1 week off treatment. Assessment with a number of tests by blinded therapists showed that his scores were no better on zolpidem and in some cases were worse on treatment. CONCLUSIONS: Ideally a series of individuals is required to assess the effect of zolpidem, but in the light of positive spin stories in the media, negative case reports should also be highlighted. It is imperative that medical treatment in all instances and certainly in low awareness states and end of life decisions is always based on firm evidence.


Assuntos
Lesões Encefálicas/tratamento farmacológico , Neurotransmissores/uso terapêutico , Estado Vegetativo Persistente/tratamento farmacológico , Piridinas/administração & dosagem , Adulto , Lesões Encefálicas/complicações , Avaliação de Medicamentos , Humanos , Masculino , Variações Dependentes do Observador , Estado Vegetativo Persistente/etiologia , Resultado do Tratamento , Zolpidem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...